“(POCRC researchers) have taken a small but potentially significant step toward early detection of ovarian cancer, finding that protein "biomarkers" released by tumors show up in women's bloodstreams years before symptoms appear, though not necessarily early enough to save lives.”

Read More

“Ovarian Cancer Action welcomes the findings of new research from the Fred Hutchison Cancer Research Center in the US, which indicates that women's reports of persistent symptoms linked to ovarian cancer — abdominal or pelvic pain, difficulty eating or feeling full quickly and abdominal bloating - when combined with the CA125 blood test, may improve the early detection of the disease.”

Read More

“Of women diagnosed with invasive breast cancer, 30 percent will develop a recurrence within five years. Eighty percent of women treated for ovarian cancer relapse after the first treatment. To prevent cancer recurrence, the UW Tumor Vaccine Group, directed by Dr. Mary L. "Nora" Disis, associate professor of medicine in the Division of Oncology, researches how to boost the immune system in cancer patients. Disis, who is also an associate member of the Fred Hutchinson Cancer Research Center, has had success with a cancer vaccine.”

Read More